Last week, GSK announced a $139 million investment to expand its Rockville manufacturing site to meet anticipated demand for its lupus drug. The expansion would allow the company to boost bulk production of a substance used in several of its drugs, including Benlysta, by about 50 percent.

The 420,000-square-foot campus and manufacturing site, 9911 Belward Campus Drive, has more than 400 employees. GSK’s investment will go toward retrofitting an existing facility at the Rockville manufacturing site, which GSK inherited when it purchased Human Genome Sciences Inc. in 2012. It will also cover demolition of existing suites, engineering, installation and validation of equipment.

This is exciting news.  GSK, like many other industry leaders, has recognized what Montgomery County can offer an organization for growth opportunities.

We need to continue the momentum and continue creating a county which is business friendly and open for business.